An EBNA3C-deleted Epstein-Barr virus (EBV) mutant causes B-cell lymphomas with delayed onset in a cord blood-humanized mouse model.
EBV causes human B-cell lymphomas and transforms B cells in vitro. EBNA3C, an EBV protein expressed in latently-infected cells, is required for EBV transformation of B cells in vitro. While EBNA3C undoubtedly plays a key role in allowing EBV to successfully infect B cells, many EBV+ lymphomas do not...
Main Authors: | James C Romero-Masters, Makoto Ohashi, Reza Djavadian, Mark R Eichelberg, Mitch Hayes, Jillian A Bristol, Shidong Ma, Erik A Ranheim, Jenny Gumperz, Eric C Johannsen, Shannon C Kenney |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2018-08-01
|
Series: | PLoS Pathogens |
Online Access: | http://europepmc.org/articles/PMC6117096?pdf=render |
Similar Items
-
EBNA2-deleted Epstein-Barr virus (EBV) isolate, P3HR1, causes Hodgkin-like lymphomas and diffuse large B cell lymphomas with type II and Wp-restricted latency types in humanized mice.
by: Chunrong Li, et al.
Published: (2020-06-01) -
Rta is the principal activator of Epstein-Barr virus epithelial lytic transcription.
by: Ahmed Ali, et al.
Published: (2022-09-01) -
B cells infected with Type 2 Epstein-Barr virus (EBV) have increased NFATc1/NFATc2 activity and enhanced lytic gene expression in comparison to Type 1 EBV infection.
by: James C Romero-Masters, et al.
Published: (2020-02-01) -
A cancer-associated Epstein-Barr virus BZLF1 promoter variant enhances lytic infection.
by: Jillian A Bristol, et al.
Published: (2018-07-01) -
Reduced IRF4 expression promotes lytic phenotype in Type 2 EBV-infected B cells.
by: Jillian A Bristol, et al.
Published: (2022-04-01)